» Articles » PMID: 7698246

Long-term Proliferation of Human Melanocytes is Supported by the Physiologic Mitogens Alpha-melanotropin, Endothelin-1, and Basic Fibroblast Growth Factor

Overview
Journal Exp Cell Res
Specialty Cell Biology
Date 1995 Apr 1
PMID 7698246
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

We have successfully established normal neonatal and adult human melanocyte cultures in a growth medium containing the physiologic mitogens basic fibroblast growth factor (bFGF; 0.6 ng/ml), endothelin-1 (endo-1; 10 nM), and alpha-melanocyte stimulating hormone (alpha-MSH; 10 nM). The latter two factors replaced the commonly used mitogens 12-O-tetradecanoylphorbol 13-acetate (TPA) and bovine pituitary extract (BPE), respectively. Basic FGF alone maintained the viability but did not induce the proliferation of melanocytes. The addition of endo-1 to the bFGF-containing medium resulted in reduction of tyrosinase activity without enhancement of proliferation. However, the addition of alpha-MSH to the bFGF-containing medium potentiated melanocyte proliferation and tyrosinase activity. The concomitant addition of endo-1, alpha-MSH, and bFGF significantly increased the entry of melanocytes into S phase and potentiated their proliferation. Melanocytes maintained under these conditions had the same tyrosinase activity as those maintained in a medium containing alpha-MSH and bFGF. The signal transduction pathway induced by either endo-1 or bFGF, but not alpha-MSH, includes the activation of the mitogen-activated (MAP) kinase pathway. The addition of both endo-1 and bFGF had more than an additive effect on the MAP kinase extracellular signal-regulated kinase 2 (ERK2). This effect was further increased by the addition of alpha-MSH to these two growth factors. In summary, we have devised a growth medium for human melanocytes based on the use of physiologic mitogens that substituted for routinely used artificial and undefined growth factors. The resulting cultures should be desirable for clinical uses and permissive for the expression of in vivo relevant responses to regulatory factors.

Citing Articles

The Keratinocyte in the Picture Cutaneous Melanoma Microenvironment.

Marrapodi R, Bellei B Cancers (Basel). 2024; 16(5).

PMID: 38473275 PMC: 10930874. DOI: 10.3390/cancers16050913.


Localized immune surveillance of primary melanoma in the skin deciphered through executable modeling.

Howell R, Davies J, Clarke M, Appios A, Mesquita I, Jayal Y Sci Adv. 2023; 9(15):eadd1992.

PMID: 37043573 PMC: 10096595. DOI: 10.1126/sciadv.add1992.


Induced pluripotent stem cells reprogramming overcomes technical limitations for highly pigmented adult melanocyte amplification and integration in 3D skin model.

Cohen C, Flouret V, Herlyn M, Fukunaga-Kalabis M, Li L, Bernerd F Pigment Cell Melanoma Res. 2022; 36(2):232-245.

PMID: 36478412 PMC: 10731472. DOI: 10.1111/pcmr.13077.


Regenerative Medicine-Based Treatment for Vitiligo: An Overview.

Bellei B, Papaccio F, Picardo M Biomedicines. 2022; 10(11).

PMID: 36359263 PMC: 9687162. DOI: 10.3390/biomedicines10112744.


Participation of keratinocyte- and fibroblast-derived factors in melanocyte homeostasis, the response to UV, and pigmentary disorders.

Upadhyay P, Ho T, Abdel-Malek Z Pigment Cell Melanoma Res. 2021; 34(4):762-776.

PMID: 33973367 PMC: 8906239. DOI: 10.1111/pcmr.12985.